Global OTC Drug Sales Market Report 2017

Publisher Name :
Date: 05-Dec-2017
No. of pages: 113
Inquire Before Buying

In this report, the global OTC Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of OTC Drug for these regions, from 2012 to 2022 (forecast), covering

- United States

- China

- Europe

- Japan

- Southeast Asia

- India

Global OTC Drug market competition by top manufacturers/players, with OTC Drug sales volume, Price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including

- Bayer HealthCare

- GlaxoSmithKline (GSK)

- Johnson&Johnson

- Pfizer

- Sanofi

- AstraZeneca

- BioGaia

- Bristol Myers Squibb

- Bukwang Pharmaceutica

- Chr. Hansen

- Cipla

- CoLucid

- Daiichi Sankyo

- Friggs

- DSM

- Eisai

- Eli Lilly

- Herbalife

- Euradite

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

- Class A

- Class B

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

- Hospital

- Clinic

- Household

If you have any special requirements, please let us know and we will offer you the report as you want.

Global OTC Drug Sales Market Report 2017

Table of Contents
Global OTC Drug Sales Market Report 2017
1 OTC Drug Market Overview
1.1 Product Overview and Scope of OTC Drug
1.2 Classification of OTC Drug by Product Category
1.2.1 Global OTC Drug Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 Global OTC Drug Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Class A
1.2.4 Class B
1.3 Global OTC Drug Market by Application/End Users
1.3.1 Global OTC Drug Sales (Volume) and Market Share Comparison by Application (2012-2022)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Household
1.4 Global OTC Drug Market by Region
1.4.1 Global OTC Drug Market Size (Value) Comparison by Region (2012-2022)
1.4.2 United States OTC Drug Status and Prospect (2012-2022)
1.4.3 China OTC Drug Status and Prospect (2012-2022)
1.4.4 Europe OTC Drug Status and Prospect (2012-2022)
1.4.5 Japan OTC Drug Status and Prospect (2012-2022)
1.4.6 Southeast Asia OTC Drug Status and Prospect (2012-2022)
1.4.7 India OTC Drug Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of OTC Drug (2012-2022)
1.5.1 Global OTC Drug Sales and Growth Rate (2012-2022)
1.5.2 Global OTC Drug Revenue and Growth Rate (2012-2022)
2 Global OTC Drug Competition by Players/Suppliers, Type and Application
2.1 Global OTC Drug Market Competition by Players/Suppliers
2.1.1 Global OTC Drug Sales and Market Share of Key Players/Suppliers (2012-2017)
2.1.2 Global OTC Drug Revenue and Share by Players/Suppliers (2012-2017)
2.2 Global OTC Drug (Volume and Value) by Type
2.2.1 Global OTC Drug Sales and Market Share by Type (2012-2017)
2.2.2 Global OTC Drug Revenue and Market Share by Type (2012-2017)
2.3 Global OTC Drug (Volume and Value) by Region
2.3.1 Global OTC Drug Sales and Market Share by Region (2012-2017)
2.3.2 Global OTC Drug Revenue and Market Share by Region (2012-2017)
2.4 Global OTC Drug (Volume) by Application
3 United States OTC Drug (Volume, Value and Sales Price)
3.1 United States OTC Drug Sales and Value (2012-2017)
3.1.1 United States OTC Drug Sales and Growth Rate (2012-2017)
3.1.2 United States OTC Drug Revenue and Growth Rate (2012-2017)
3.1.3 United States OTC Drug Sales Price Trend (2012-2017)
3.2 United States OTC Drug Sales Volume and Market Share by Players
3.3 United States OTC Drug Sales Volume and Market Share by Type
3.4 United States OTC Drug Sales Volume and Market Share by Application
4 China OTC Drug (Volume, Value and Sales Price)
4.1 China OTC Drug Sales and Value (2012-2017)
4.1.1 China OTC Drug Sales and Growth Rate (2012-2017)
4.1.2 China OTC Drug Revenue and Growth Rate (2012-2017)
4.1.3 China OTC Drug Sales Price Trend (2012-2017)
4.2 China OTC Drug Sales Volume and Market Share by Players
4.3 China OTC Drug Sales Volume and Market Share by Type
4.4 China OTC Drug Sales Volume and Market Share by Application
5 Europe OTC Drug (Volume, Value and Sales Price)
5.1 Europe OTC Drug Sales and Value (2012-2017)
5.1.1 Europe OTC Drug Sales and Growth Rate (2012-2017)
5.1.2 Europe OTC Drug Revenue and Growth Rate (2012-2017)
5.1.3 Europe OTC Drug Sales Price Trend (2012-2017)
5.2 Europe OTC Drug Sales Volume and Market Share by Players
5.3 Europe OTC Drug Sales Volume and Market Share by Type
5.4 Europe OTC Drug Sales Volume and Market Share by Application
6 Japan OTC Drug (Volume, Value and Sales Price)
6.1 Japan OTC Drug Sales and Value (2012-2017)
6.1.1 Japan OTC Drug Sales and Growth Rate (2012-2017)
6.1.2 Japan OTC Drug Revenue and Growth Rate (2012-2017)
6.1.3 Japan OTC Drug Sales Price Trend (2012-2017)
6.2 Japan OTC Drug Sales Volume and Market Share by Players
6.3 Japan OTC Drug Sales Volume and Market Share by Type
6.4 Japan OTC Drug Sales Volume and Market Share by Application
7 Southeast Asia OTC Drug (Volume, Value and Sales Price)
7.1 Southeast Asia OTC Drug Sales and Value (2012-2017)
7.1.1 Southeast Asia OTC Drug Sales and Growth Rate (2012-2017)
7.1.2 Southeast Asia OTC Drug Revenue and Growth Rate (2012-2017)
7.1.3 Southeast Asia OTC Drug Sales Price Trend (2012-2017)
7.2 Southeast Asia OTC Drug Sales Volume and Market Share by Players
7.3 Southeast Asia OTC Drug Sales Volume and Market Share by Type
7.4 Southeast Asia OTC Drug Sales Volume and Market Share by Application
8 India OTC Drug (Volume, Value and Sales Price)
8.1 India OTC Drug Sales and Value (2012-2017)
8.1.1 India OTC Drug Sales and Growth Rate (2012-2017)
8.1.2 India OTC Drug Revenue and Growth Rate (2012-2017)
8.1.3 India OTC Drug Sales Price Trend (2012-2017)
8.2 India OTC Drug Sales Volume and Market Share by Players
8.3 India OTC Drug Sales Volume and Market Share by Type
8.4 India OTC Drug Sales Volume and Market Share by Application
9 Global OTC Drug Players/Suppliers Profiles and Sales Data
9.1 Bayer HealthCare
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 OTC Drug Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Bayer HealthCare OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.1.4 Main Business/Business Overview
9.2 GlaxoSmithKline (GSK)
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 OTC Drug Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 GlaxoSmithKline (GSK) OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.2.4 Main Business/Business Overview
9.3 Johnson&Johnson
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 OTC Drug Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Johnson&Johnson OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.3.4 Main Business/Business Overview
9.4 Pfizer
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 OTC Drug Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Pfizer OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.4.4 Main Business/Business Overview
9.5 Sanofi
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 OTC Drug Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Sanofi OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.5.4 Main Business/Business Overview
9.6 AstraZeneca
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 OTC Drug Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 AstraZeneca OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.6.4 Main Business/Business Overview
9.7 BioGaia
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 OTC Drug Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 BioGaia OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.7.4 Main Business/Business Overview
9.8 Bristol Myers Squibb
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 OTC Drug Product Category, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 Bristol Myers Squibb OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.8.4 Main Business/Business Overview
9.9 Bukwang Pharmaceutica
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 OTC Drug Product Category, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 Bukwang Pharmaceutica OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.9.4 Main Business/Business Overview
9.10 Chr. Hansen
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 OTC Drug Product Category, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 Chr. Hansen OTC Drug Sales, Revenue, Price and Gross Margin (2012-2017)
9.10.4 Main Business/Business Overview
9.11 Cipla
9.12 CoLucid
9.13 Daiichi Sankyo
9.14 Friggs
9.15 DSM
9.16 Eisai
9.17 Eli Lilly
9.18 Herbalife
9.19 Euradite
10 OTC Drug Maufacturing Cost Analysis
10.1 OTC Drug Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of OTC Drug
10.3 Manufacturing Process Analysis of OTC Drug
11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 OTC Drug Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of OTC Drug Major Manufacturers in 2016
11.4 Downstream Buyers
12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change
14 Global OTC Drug Market Forecast (2017-2022)
14.1 Global OTC Drug Sales Volume, Revenue and Price Forecast (2017-2022)
14.1.1 Global OTC Drug Sales Volume and Growth Rate Forecast (2017-2022)
14.1.2 Global OTC Drug Revenue and Growth Rate Forecast (2017-2022)
14.1.3 Global OTC Drug Price and Trend Forecast (2017-2022)
14.2 Global OTC Drug Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
14.2.1 Global OTC Drug Sales Volume and Growth Rate Forecast by Regions (2017-2022)
14.2.2 Global OTC Drug Revenue and Growth Rate Forecast by Regions (2017-2022)
14.2.3 United States OTC Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.4 China OTC Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.5 Europe OTC Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.6 Japan OTC Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.7 Southeast Asia OTC Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.8 India OTC Drug Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global OTC Drug Sales Volume, Revenue and Price Forecast by Type (2017-2022)
14.3.1 Global OTC Drug Sales Forecast by Type (2017-2022)
14.3.2 Global OTC Drug Revenue Forecast by Type (2017-2022)
14.3.3 Global OTC Drug Price Forecast by Type (2017-2022)
14.4 Global OTC Drug Sales Volume Forecast by Application (2017-2022)
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer
List of Tables and Figures
Figure Product Picture of OTC Drug
Figure Global OTC Drug Sales Volume Comparison (K Pcs) by Type (2012-2022)
Figure Global OTC Drug Sales Volume Market Share by Type (Product Category) in 2016
Figure Class A Product Picture
Figure Class B Product Picture
Figure Global OTC Drug Sales Comparison (K Pcs) by Application (2012-2022)
Figure Global Sales Market Share of OTC Drug by Application in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Household Examples
Table Key Downstream Customer in Household
Figure Global OTC Drug Market Size (Million USD) by Regions (2012-2022)
Figure United States OTC Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure China OTC Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe OTC Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan OTC Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia OTC Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure India OTC Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global OTC Drug Sales Volume (K Pcs) and Growth Rate (2012-2022)
Figure Global OTC Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Market Major Players OTC Drug Sales Volume (K Pcs) (2012-2017)
Table Global OTC Drug Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table Global OTC Drug Sales Share by Players/Suppliers (2012-2017)
Figure 2016 OTC Drug Sales Share by Players/Suppliers
Figure 2017 OTC Drug Sales Share by Players/Suppliers
Figure Global OTC Drug Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global OTC Drug Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global OTC Drug Revenue Share by Players/Suppliers (2012-2017)
Table 2016 Global OTC Drug Revenue Share by Players
Table 2017 Global OTC Drug Revenue Share by Players
Table Global OTC Drug Sales (K Pcs) and Market Share by Type (2012-2017)
Table Global OTC Drug Sales Share (K Pcs) by Type (2012-2017)
Figure Sales Market Share of OTC Drug by Type (2012-2017)
Figure Global OTC Drug Sales Growth Rate by Type (2012-2017)
Table Global OTC Drug Revenue (Million USD) and Market Share by Type (2012-2017)
Table Global OTC Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of OTC Drug by Type (2012-2017)
Figure Global OTC Drug Revenue Growth Rate by Type (2012-2017)
Table Global OTC Drug Sales Volume (K Pcs) and Market Share by Region (2012-2017)
Table Global OTC Drug Sales Share by Region (2012-2017)
Figure Sales Market Share of OTC Drug by Region (2012-2017)
Figure Global OTC Drug Sales Growth Rate by Region in 2016
Table Global OTC Drug Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global OTC Drug Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of OTC Drug by Region (2012-2017)
Figure Global OTC Drug Revenue Growth Rate by Region in 2016
Table Global OTC Drug Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global OTC Drug Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of OTC Drug by Region (2012-2017)
Figure Global OTC Drug Revenue Market Share by Region in 2016
Table Global OTC Drug Sales Volume (K Pcs) and Market Share by Application (2012-2017)
Table Global OTC Drug Sales Share (%) by Application (2012-2017)
Figure Sales Market Share of OTC Drug by Application (2012-2017)
Figure Global OTC Drug Sales Market Share by Application (2012-2017)
Figure United States OTC Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure United States OTC Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure United States OTC Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table United States OTC Drug Sales Volume (K Pcs) by Players (2012-2017)
Table United States OTC Drug Sales Volume Market Share by Players (2012-2017)
Figure United States OTC Drug Sales Volume Market Share by Players in 2016
Table United States OTC Drug Sales Volume (K Pcs) by Type (2012-2017)
Table United States OTC Drug Sales Volume Market Share by Type (2012-2017)
Figure United States OTC Drug Sales Volume Market Share by Type in 2016
Table United States OTC Drug Sales Volume (K Pcs) by Application (2012-2017)
Table United States OTC Drug Sales Volume Market Share by Application (2012-2017)
Figure United States OTC Drug Sales Volume Market Share by Application in 2016
Figure China OTC Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure China OTC Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure China OTC Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table China OTC Drug Sales Volume (K Pcs) by Players (2012-2017)
Table China OTC Drug Sales Volume Market Share by Players (2012-2017)
Figure China OTC Drug Sales Volume Market Share by Players in 2016
Table China OTC Drug Sales Volume (K Pcs) by Type (2012-2017)
Table China OTC Drug Sales Volume Market Share by Type (2012-2017)
Figure China OTC Drug Sales Volume Market Share by Type in 2016
Table China OTC Drug Sales Volume (K Pcs) by Application (2012-2017)
Table China OTC Drug Sales Volume Market Share by Application (2012-2017)
Figure China OTC Drug Sales Volume Market Share by Application in 2016
Figure Europe OTC Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Europe OTC Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure Europe OTC Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table Europe OTC Drug Sales Volume (K Pcs) by Players (2012-2017)
Table Europe OTC Drug Sales Volume Market Share by Players (2012-2017)
Figure Europe OTC Drug Sales Volume Market Share by Players in 2016
Table Europe OTC Drug Sales Volume (K Pcs) by Type (2012-2017)
Table Europe OTC Drug Sales Volume Market Share by Type (2012-2017)
Figure Europe OTC Drug Sales Volume Market Share by Type in 2016
Table Europe OTC Drug Sales Volume (K Pcs) by Application (2012-2017)
Table Europe OTC Drug Sales Volume Market Share by Application (2012-2017)
Figure Europe OTC Drug Sales Volume Market Share by Application in 2016
Figure Japan OTC Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Japan OTC Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan OTC Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table Japan OTC Drug Sales Volume (K Pcs) by Players (2012-2017)
Table Japan OTC Drug Sales Volume Market Share by Players (2012-2017)
Figure Japan OTC Drug Sales Volume Market Share by Players in 2016
Table Japan OTC Drug Sales Volume (K Pcs) by Type (2012-2017)
Table Japan OTC Drug Sales Volume Market Share by Type (2012-2017)
Figure Japan OTC Drug Sales Volume Market Share by Type in 2016
Table Japan OTC Drug Sales Volume (K Pcs) by Application (2012-2017)
Table Japan OTC Drug Sales Volume Market Share by Application (2012-2017)
Figure Japan OTC Drug Sales Volume Market Share by Application in 2016
Figure Southeast Asia OTC Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure Southeast Asia OTC Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia OTC Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table Southeast Asia OTC Drug Sales Volume (K Pcs) by Players (2012-2017)
Table Southeast Asia OTC Drug Sales Volume Market Share by Players (2012-2017)
Figure Southeast Asia OTC Drug Sales Volume Market Share by Players in 2016
Table Southeast Asia OTC Drug Sales Volume (K Pcs) by Type (2012-2017)
Table Southeast Asia OTC Drug Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia OTC Drug Sales Volume Market Share by Type in 2016
Table Southeast Asia OTC Drug Sales Volume (K Pcs) by Application (2012-2017)
Table Southeast Asia OTC Drug Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia OTC Drug Sales Volume Market Share by Application in 2016
Figure India OTC Drug Sales (K Pcs) and Growth Rate (2012-2017)
Figure India OTC Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure India OTC Drug Sales Price (USD/Pcs) Trend (2012-2017)
Table India OTC Drug Sales Volume (K Pcs) by Players (2012-2017)
Table India OTC Drug Sales Volume Market Share by Players (2012-2017)
Figure India OTC Drug Sales Volume Market Share by Players in 2016
Table India OTC Drug Sales Volume (K Pcs) by Type (2012-2017)
Table India OTC Drug Sales Volume Market Share by Type (2012-2017)
Figure India OTC Drug Sales Volume Market Share by Type in 2016
Table India OTC Drug Sales Volume (K Pcs) by Application (2012-2017)
Table India OTC Drug Sales Volume Market Share by Application (2012-2017)
Figure India OTC Drug Sales Volume Market Share by Application in 2016
Table Bayer HealthCare Basic Information List
Table Bayer HealthCare OTC Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bayer HealthCare OTC Drug Sales Growth Rate (2012-2017)
Figure Bayer HealthCare OTC Drug Sales Global Market Share (2012-2017
Figure Bayer HealthCare OTC Drug Revenue Global Market Share (2012-2017)
Table GlaxoSmithKline (GSK) Basic Information List
Table GlaxoSmithKline (GSK) OTC Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure GlaxoSmithKline (GSK) OTC Drug Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline (GSK) OTC Drug Sales Global Market Share (2012-2017
Figure GlaxoSmithKline (GSK) OTC Drug Revenue Global Market Share (2012-2017)
Table Johnson&Johnson Basic Information List
Table Johnson&Johnson OTC Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Johnson&Johnson OTC Drug Sales Growth Rate (2012-2017)
Figure Johnson&Johnson OTC Drug Sales Global Market Share (2012-2017
Figure Johnson&Johnson OTC Drug Revenue Global Market Share (2012-2017)
Table Pfizer Basic Information List
Table Pfizer OTC Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Pfizer OTC Drug Sales Growth Rate (2012-2017)
Figure Pfizer OTC Drug Sales Global Market Share (2012-2017
Figure Pfizer OTC Drug Revenue Global Market Share (2012-2017)
Table Sanofi Basic Information List
Table Sanofi OTC Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Sanofi OTC Drug Sales Growth Rate (2012-2017)
Figure Sanofi OTC Drug Sales Global Market Share (2012-2017
Figure Sanofi OTC Drug Revenue Global Market Share (2012-2017)
Table AstraZeneca Basic Information List
Table AstraZeneca OTC Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure AstraZeneca OTC Drug Sales Growth Rate (2012-2017)
Figure AstraZeneca OTC Drug Sales Global Market Share (2012-2017
Figure AstraZeneca OTC Drug Revenue Global Market Share (2012-2017)
Table BioGaia Basic Information List
Table BioGaia OTC Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure BioGaia OTC Drug Sales Growth Rate (2012-2017)
Figure BioGaia OTC Drug Sales Global Market Share (2012-2017
Figure BioGaia OTC Drug Revenue Global Market Share (2012-2017)
Table Bristol Myers Squibb Basic Information List
Table Bristol Myers Squibb OTC Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bristol Myers Squibb OTC Drug Sales Growth Rate (2012-2017)
Figure Bristol Myers Squibb OTC Drug Sales Global Market Share (2012-2017
Figure Bristol Myers Squibb OTC Drug Revenue Global Market Share (2012-2017)
Table Bukwang Pharmaceutica Basic Information List
Table Bukwang Pharmaceutica OTC Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bukwang Pharmaceutica OTC Drug Sales Growth Rate (2012-2017)
Figure Bukwang Pharmaceutica OTC Drug Sales Global Market Share (2012-2017
Figure Bukwang Pharmaceutica OTC Drug Revenue Global Market Share (2012-2017)
Table Chr. Hansen Basic Information List
Table Chr. Hansen OTC Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Chr. Hansen OTC Drug Sales Growth Rate (2012-2017)
Figure Chr. Hansen OTC Drug Sales Global Market Share (2012-2017
Figure Chr. Hansen OTC Drug Revenue Global Market Share (2012-2017)
Table Cipla Basic Information List
Table CoLucid Basic Information List
Table Daiichi Sankyo Basic Information List
Table Friggs Basic Information List
Table DSM Basic Information List
Table Eisai Basic Information List
Table Eli Lilly Basic Information List
Table Herbalife Basic Information List
Table Euradite Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of OTC Drug
Figure Manufacturing Process Analysis of OTC Drug
Figure OTC Drug Industrial Chain Analysis
Table Raw Materials Sources of OTC Drug Major Players in 2016
Table Major Buyers of OTC Drug
Table Distributors/Traders List
Figure Global OTC Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Global OTC Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global OTC Drug Price (USD/Pcs) and Trend Forecast (2017-2022)
Table Global OTC Drug Sales Volume (K Pcs) Forecast by Regions (2017-2022)
Figure Global OTC Drug Sales Volume Market Share Forecast by Regions (2017-2022)
Figure Global OTC Drug Sales Volume Market Share Forecast by Regions in 2022
Table Global OTC Drug Revenue (Million USD) Forecast by Regions (2017-2022)
Figure Global OTC Drug Revenue Market Share Forecast by Regions (2017-2022)
Figure Global OTC Drug Revenue Market Share Forecast by Regions in 2022
Figure United States OTC Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States OTC Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure China OTC Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure China OTC Drug Revenue and Growth Rate Forecast (2017-2022)
Figure Europe OTC Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Europe OTC Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan OTC Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Japan OTC Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia OTC Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia OTC Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India OTC Drug Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure India OTC Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Global OTC Drug Sales (K Pcs) Forecast by Type (2017-2022)
Figure Global OTC Drug Sales Volume Market Share Forecast by Type (2017-2022)
Table Global OTC Drug Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global OTC Drug Revenue Market Share Forecast by Type (2017-2022)
Table Global OTC Drug Price (USD/Pcs) Forecast by Type (2017-2022)
Table Global OTC Drug Sales (K Pcs) Forecast by Application (2017-2022)
Figure Global OTC Drug Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • China Transcatheter Mitral Valve Repair and Replacement Market Research Report 2018
    Published: 24-Apr-2018        Price: US 3400 Onwards        Pages: 102
    The global Transcatheter Mitral Valve Repair and Replacement market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. China plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of xx%. This report studies the Transcatheter Mitral Valve Repair and Replacement development status and future trend i......
  • China Tissue Engineered Bone Market Research Report 2018
    Published: 24-Apr-2018        Price: US 3400 Onwards        Pages: 101
    The global Tissue Engineered Bone market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. China plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of xx%. This report studies the Tissue Engineered Bone development status and future trend in China, focuses on top players in China, also splits ......
  • China Theobroma Oil Market Research Report 2018
    Published: 24-Apr-2018        Price: US 3400 Onwards        Pages: 104
    The global Theobroma Oil market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. China plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of xx%. This report studies the Theobroma Oil development status and future trend in China, focuses on top players in China, also splits Theobroma Oil by t......
  • China Superoxide Dismutase [Cu-Zn] Market Research Report 2018
    Published: 24-Apr-2018        Price: US 3400 Onwards        Pages: 97
    The global Superoxide Dismutase [Cu-Zn] market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. China plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of xx%. This report studies the Superoxide Dismutase [Cu-Zn] development status and future trend in China, focuses on top players in China, ......
  • China Receptor Tyrosine Protein Kinase ERBB 4 Market Research Report 2018
    Published: 24-Apr-2018        Price: US 3400 Onwards        Pages: 113
    The global Receptor Tyrosine Protein Kinase ERBB 4 market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. China plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of xx%. This report studies the Receptor Tyrosine Protein Kinase ERBB 4 development status and future trend in China, focuses on ......
  • China RAF Proto Oncogene Serine/Threonine Protein Kinase Market Research Report 2018
    Published: 24-Apr-2018        Price: US 3400 Onwards        Pages: 100
    The global RAF Proto Oncogene Serine/Threonine Protein Kinase market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. China plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of xx%. This report studies the RAF Proto Oncogene Serine/Threonine Protein Kinase development status and future trend......
  • China Radix Isatidis Market Research Report 2018
    Published: 24-Apr-2018        Price: US 3400 Onwards        Pages: 100
    The global Radix Isatidis market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. China plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of xx%. This report studies the Radix Isatidis development status and future trend in China, focuses on top players in China, also splits Radix Isatidis b......
  • China Protein Kinase C Epsilon Type Market Research Report 2018
    Published: 24-Apr-2018        Price: US 3400 Onwards        Pages: 96
    The global Protein Kinase C Epsilon Type market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. China plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of xx%. This report studies the Protein Kinase C Epsilon Type development status and future trend in China, focuses on top players in China......
  • China Proprotein Convertase Subtilisin/Kexin Type 9 Market Research Report 2018
    Published: 24-Apr-2018        Price: US 3400 Onwards        Pages: 113
    The global Proprotein Convertase Subtilisin/Kexin Type 9 market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. China plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of xx%. This report studies the Proprotein Convertase Subtilisin/Kexin Type 9 development status and future trend in China,......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs